Inventor · disambiguated record
Philippe Valet
Also filed as: VALET PHILIPPE
6 granted patents·6 pending applications·6 citations·filing 2003–2024
71Inventor score
Files withINST NAT SANTE RECH MED7INSERM INSITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE2UNIV TOULOUSE 3 PAUL SABATIER2AGRONOMIQUE INST NAT RECH1
Top patents by PatentIndex Score
12 records- 0167US11896649B2Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunctionINST NAT SANTE RECH MED·Filed 2022·Granted Feb 13, 2024·0 cites·13 claims
- 0267US7618951B2Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetesAGRONOMIQUE INST NAT RECH·Filed 2003·Granted Nov 17, 2009·6 cites·5 claims
- 0367US2024226238A1Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunctionINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0465US2025090529A1Use of shp2 inhibitors for the treatment of insulin resistanceINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0557US2022000869A1Use of shp2 inhibitors for the treatment of insulin resistanceINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0654US2025134885A1Use of shp2 inhibitors for inhibiting senescenceINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0753US11484577B2Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunctionINST NAT SANTE RECH MED·Filed 2017·Granted Nov 1, 2022·0 cites·12 claims
- 0845US2020171127A1Method and pharmaceutical composition for use in the treatment of diabetesINSERM INSITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2019·Application pending·0 cites
- 0943US10426818B2Method and pharmaceutical composition for use in the treatment of diabetesINSERM INSITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2016·Granted Oct 1, 2019·0 cites·5 claims
- 1042US2020081009A1Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate CancerUNIV TOULOUSE 3 PAUL SABATIER·Filed 2019·Application pending·0 cites
- 1138US10401365B2Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancerUNIV TOULOUSE 3 PAUL SABATIER·Filed 2015·Granted Sep 3, 2019·0 cites·6 claims
- 1236US9381229B2Pharmaceutical composition for use in the treatment of dysfunction associated with agingINST NAT SANTE RECH MED·Filed 2012·Granted Jul 5, 2016·0 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →